From: Associations of multiple serum biomarkers and the risk of cardiovascular disease in China
biomarkers | n | Min | 25th | 50th | 75th | Max | P | |
---|---|---|---|---|---|---|---|---|
TSH (mIU/L) | 0.734 | |||||||
Case | 161 | 0.16 | 1.36 | 1.98 | 2.83 | 21.99 | ||
Control | 160 | 0.06 | 1.39 | 1.95 | 2.84 | 12.24 | ||
FT3 (pmol/L) | 0.153 | |||||||
Case | 161 | 2.27 | 4.51 | 4.99 | 5.46 | 7.04 | ||
Control | 160 | 2.03 | 4.40 | 4.79 | 5.38 | 7.40 | ||
FT4 (pmol/L) | 0.032 | |||||||
Case | 161 | 6.30 | 15.99 | 17.92 | 19.43 | 23.72 | ||
Control | 160 | 10.40 | 15.01 | 17.14 | 19.13 | 25.02 | ||
T3 (nmol/L) | 0.976 | |||||||
Case | 161 | 1.34 | 1.69 | 1.98 | 2.25 | 3.28 | ||
Control | 160 | 1.28 | 1.76 | 1.98 | 2.20 | 2.96 | ||
T4 (nmol/L) | 0.299 | |||||||
Case | 161 | 49.08 | 90.66 | 105.50 | 118.50 | 165.30 | ||
Control | 160 | 54.28 | 86.13 | 101.45 | 118.38 | 168.70 | ||
GLU (mmol/L) | < 0.001 | |||||||
Case | 161 | 1.11 | 4.95 | 5.66 | 6.95 | 16.46 | ||
Control | 160 | 3.95 | 4.74 | 5.10 | 5.75 | 14.31 | ||
CREA (μ mol/L) | 0.299 | |||||||
Case | 161 | 35.00 | 51.00 | 61.00 | 71.00 | 160.00 | ||
Control | 160 | 32.00 | 52.00 | 60.50 | 69.00 | 621.00 | ||
UA (μ mol/L) | 0.061 | |||||||
Case | 161 | 45.00 | 235.50 | 276.00 | 328.50 | 573.00 | ||
Control | 160 | 113.00 | 217.00 | 265.00 | 312.00 | 638.00 | ||
TC (mmol/L) | 0.214 | |||||||
Case | 161 | 2.31 | 4.27 | 4.98 | 5.57 | 7.67 | ||
Control | 160 | 2.59 | 4.18 | 4.72 | 5.49 | 8.18 | ||
TG (mmol/L) | < 0.001 | |||||||
Case | 161 | 0.54 | 1.15 | 1.61 | 2.19 | 9.14 | ||
Control | 160 | 0.34 | 0.87 | 1.27 | 1.72 | 7.76 | ||
HDL-c (mmol/L) | 0.018 | |||||||
Case | 161 | 0.50 | 0.92 | 1.06 | 1.26 | 2.13 | ||
Control | 160 | 0.50 | 0.98 | 1.11 | 1.32 | 1.91 | ||
LDL-c (mmol/L) | 0.013 | |||||||
Case | 161 | 1.32 | 2.48 | 2.89 | 3.41 | 6.44 | ||
Control | 160 | 0.97 | 2.30 | 2.70 | 3.15 | 5.23 | ||
HCY (μ mol/L) | 0.693 | |||||||
Case | 161 | 5.50 | 9.35 | 11.10 | 13.50 | 44.50 | ||
Control | 160 | 4.60 | 9.60 | 11.20 | 13.78 | 60.70 |